Skip to main content


Fig. 5 | Parasites & Vectors

Fig. 5

From: A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection

Fig. 5

Percentage egg developmental stages (oogram pattern) in infected mice treated with SLN-PZQ or market PZQ. Mice were sacrificed 14 days after treatment. Data are presented as the means ± SEM. n = 6–8 mice per group. Significant difference vs M-PZQ at P < 0.05. Abbreviations: SLN-PZQ, solid lipid nanoparticle praziquantel; M-PZQ, market praziquantel

Back to article page